R. Whittle

First name
R.
Last name
Whittle
Bajpai, R., Partington, R., Muller, S., Forrester, H., Mallen, C. D., Clarson, L., et al. (2024). Prognostic factors for colchicine prophylaxis-related adverse events when initiating allopurinol for gout: retrospective cohort study. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/keae229
View
Muller, S., Bailey, J., Bajpai, R., Helliwell, T., Harrisson, S. A., Whittle, R., et al. (2024). Risk of adverse outcomes during gabapentinoid therapy and factors associated with increased risk in UK primary care using the clinical practice research datalink: a cohort study. Pain. http://doi.org/10.1097/j.pain.0000000000003239
View
Roddy, E., Bajpai, R., Forrester, H., Partington, R. J., Mallen, C. D., Clarson, L. E., et al. (2023). Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK Clinical Practice Research Datalink. Ann Rheum Dis. http://doi.org/10.1136/ard-2023-224154
View
Scott, I. C., Whittle, R., Bailey, J., Twohig, H., Hider, S. L., Mallen, C. D., et al. (2023). Analgesic prescribing in patients with inflammatory arthritis in England: observational studies in the Clinical Practice Research Datalink. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/kead463
View
Scott, I. C., Whittle, R., Bailey, J., Twohig, H., Hider, S. L., Mallen, C. D., et al. (2022). Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: An observational study using primary care electronic health record data. Lancet Reg Health Eur, 23, 100519. http://doi.org/10.1016/j.lanepe.2022.100519
View
Sultan, A., Mallen, C., Hayward, R., Muller, S., Whittle, R., Hotston, M., & Roddy, E. (2017). Gout and subsequent erectile dysfunction: a population-based cohort study from England. Arthritis Res Ther. http://doi.org/10.1186/s13075-017-1322-0
View
Roughley, M., Sultan, A. A., Clarson, L., Muller, S., Whittle, R., Belcher, J., et al. (2018). Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study. Arthritis Res Ther. http://doi.org/10.1186/s13075-018-1746-1
View
Paskins, Z., Whittle, R., Sultan, A. A., Muller, S., Blagojevic-Bucknall, M., Helliwell, T., et al. (2018). Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study. BMC Med. http://doi.org/10.1186/s12916-017-0987-1
View
Sultan, A. A., Whittle, R., Muller, S., Roddy, E., Mallen, C. D., Bucknall, M., et al. (2018). Risk of fragility fracture among patients with gout and the effect of urate-lowering therapy. Cmaj. http://doi.org/10.1503/cmaj.170806
View
Paskins, Z., Whittle, R., Sultan, A., Muller, S., Blagojevic-Bucknall, M., Helliwell, T., et al. (2018). Risk of fragility fracture among patients with late-onset psoriasis: a UK population-based study. Osteoporos Int. http://doi.org/10.1007/s00198-018-4491-z
View